Global Alprazolam Powder Market to Grow at a CAGR of 3.6% During 2021-2026, Aided by the Rising Rates of Anxiety Disorders

The alprazolam powder industry is being driven by the rising anxiety disorders across the globe, with alprazolam being the primary ingredient in leading anti-anxiety drugs. According to the World Health Organisation, mental illnesses account for nearly 15% of the overall disease conditions globally, with over 300 million people suffering from anxiety disorders.

In the United States, nearly 1 in 5 adults have been estimated to suffer from anxiety disorders, with generalised anxiety disorder rates increasing among the teenage population of the country. Due to the significant proportion of the population relying on alprazolam-based anxiety medications in the United States, the alprazolam powder industry in the country is witnessing a robust growth. The Asia Pacific is also expected to emerge as a significant market for alprazolam powder due to the rising pharmaceutical industry and the growing de-stigmatisation of mental health-related disorders, which is leading to a wider range of people seeking treatment. The rising mental-health awareness campaigns and programmes, like Swach Mansikta Abhiyan and accredited social health activist (ASHA) programme initiated by the Government of India, are expected to further aid the market growth in the Asia Pacific.

Pfizer Inc. (NYSE: PFE) is one of the leading players in the alprazolam powder industry. The company is the manufacturer of Xanax, which has almost become synonymous with alprazolam-based anti-anxiety tablets. Xanax became a part of Pfizer’s portfolio upon its acquisition of Pharmacia, which had earlier bought Upjohn, the company which initially started commercially producing Xanax. With benzodiazepines like Xanax still being one of the most commonly prescribed anti-anxiety drugs, Pfizer is expected to remain of the most significant players in the alprazolam powder industry.

Market Analysis by Type, Application, End Use, and Region:

• The market, on the basis of type, can be divided into compressed tablets and extended release capsules.
• Based on application, the industry can be divided into panic disorders, anxiety, depression, insomnia, and others.
• The major end-use segments in the industry are research institutes and pharmaceutical companies, among others.
• The regional markets for alprazolam powder include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The rising awareness of anxiety disorders is leading to the growth of the market.
• The growing demand from emerging countries due to the increasing de-stigmatisation of anxiety and panic disorders is further catalysing the market growth.
• The market is expected to witness a further expansion in the coming years due to the rising R&D activities by the players involved in the industry.
• The rising government support and growing pharmaceutical industry are expected to provide further impetus to the market growth.
• The increasing geriatric population is also expected to support the market expansion in the coming years.

Key Offerings of the Report:

• The EMR report gives an overview of the market for the periods (2016-2020) and (2021-2026).
• The report also offers the historical (2016-2020) and forecast (2021-2026) markets for the types, applications, end uses, and major regions of alprazolam powder.
• It assesses the regional price trends for the (2016-2020) and (2021-2026) periods.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global alprazolam powder market are Pfizer Inc., Terrace Pharmaceuticals, and Sandoz AG, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.